Breadcrumb
RI-MUHC team builds a new model to study Nager and Rodriguez syndromes, revealing crucial information about the role of the SF3B4 gene
Tuesdays, 1 p.m. to 2:30 p.m.
SIS Program Seminar Series Fall 2024
Impressive cooperation from research programs brings new success to the RI-MUHC waste recycling and sustainability efforts
RI-MUHC ANNUAL REPORT 2024OUTREACHIn 2023-2024, outreach initiatives at the RI-MUHC were as multifaceted as our research teams. This...
RI-MUHC ANNUAL REPORT 2024EQUITY, DIVERSITY AND INCLUSION (EDI) INITIATIVESREPRESENTING AND RESPONDING TO THE POPULATION’S...
International clinical trial shows perioperative immunotherapy prolongs life in non-small-cell lung cancer patients.
RI-MUHC ANNUAL REPORT 2024EXECUTIVE MESSAGESMESSAGE FROM DR. RHIAN TOUYZ, RI-MUHCMESSAGE FROM DR. LUCIE OPATRNY, MUHCMESSAGE FROM LESLEY...
RI-MUHC ANNUAL REPORT 2024AWARDS AND RECOGNITIONRESEARCHERS HONOUREDAmong the RI-MUHC’s rising stars and future leaders: Marilyn Ahun,...
RI-MUHC ANNUAL REPORT 2024FUNDING SUMMARYWe are proud of our researchers’ success in funding competitions and grateful to the wide range of...
Newest Fellows and Members to the College of New Scholars, Artists and Scientists recognized for scholarly...
RI-MUHC ANNUAL REPORT 2024SELECTED HIGH-IMPACT PUBLICATIONSBRAIN REPAIR AND INTEGRATIVE NEUROSCIENCE (BRaIN) PROGRAMCANCER RESEARCH PROGRAM...
RI-MUHC researcher leads the development of the first multimodal deep learning model to optimize care for individual cancer patients
This is your chance to explore the latest applications developed by our platforms, experience state-of-the-art technologies firsthand, and uncover exciting opportunities to accelerate your research.
Registration Deadline: Thursday, September 26th
Registration Deadline: Thursday, September 26th
Study shows that despite some improvements, potentially inappropriate medications are still heavily prescribed to seniors in Canada and some are...
RI-MUHC ANNUAL REPORT 2024TRAINING AND MENTORING HIGHLIGHTSCANADIAN CONSORTIUM OF CLINICAL TRIAL TRAINING TAKES OFF SUCCESSFULLYOUR DCAT...
RI-MUHC ANNUAL REPORT 2024TRAINEE SUCCESSESWhat is our new generation of researchers achieving today?Over 1,300 research trainees play a...
Location: Cruess Amphitheatre, ES1.1129, Glen site, RI-MUHC
Topic: Interstitial Lung Diseases
Host: Darcy Wagner, PhD
Thursdays, 4 p.m. to 5 p.m.
MeDiC Program Seminar Series Fall 2024
Fall 2024